The latest closing stock price for Stoke Therapeutics as of March 28, 2025 is 7.21.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-718 today, roughly -1 times their original investment - a -19.02% compound annual growth rate over 6 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 143.8% above the current share price.
The Stoke Therapeutics 52-week low stock price is 7.06, which is 2.1% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 12.38.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-718 today, roughly -1 times their original investment - a -19.02% compound annual growth rate over 6 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 143.8% above the current share price.
The Stoke Therapeutics 52-week low stock price is 7.06, which is 2.1% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 12.38.